Clinicopathological features and perioperative outcomes of robot-assisted thoracoscopic surgery for primary lung cancer: An analysis of initial outcomes based on the National Clinical Database.

IF 1.6 4区 医学 Q2 SURGERY
Surgery Today Pub Date : 2025-08-01 Epub Date: 2025-02-07 DOI:10.1007/s00595-025-02992-5
Tomohiro Haruki, Hiroyuki Yamamoto, Yasushi Hoshikawa, Hisashi Iwata, Yukio Sato, Kenji Suzuki, Ichiro Yoshino
{"title":"Clinicopathological features and perioperative outcomes of robot-assisted thoracoscopic surgery for primary lung cancer: An analysis of initial outcomes based on the National Clinical Database.","authors":"Tomohiro Haruki, Hiroyuki Yamamoto, Yasushi Hoshikawa, Hisashi Iwata, Yukio Sato, Kenji Suzuki, Ichiro Yoshino","doi":"10.1007/s00595-025-02992-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To analyze the clinicopathological features and perioperative outcomes of patients who underwent robot-assisted thoracoscopic surgery (RATS) for primary lung cancer in the initial period after insurance approval in Japan.</p><p><strong>Methods: </strong>The data source was the National Clinical Database, using four annual datasets (2018, 2019, 2020, and 2021) that included information on individuals who underwent lobectomy with lymph-node dissection via robot-assisted thoracoscopic surgery for primary lung cancer. Clinicopathological features and perioperative outcomes by year were analyzed descriptively.</p><p><strong>Results: </strong>The median console time was reduced by 22 min from 2018 to 2021 (from 171 min to 149 min, respectively). The median overall operative time was also reduced by 29 min from 2018 to 2021 (from 245 min to 216 min, respectively). The conversion rate from robotic to other approaches was 3.5% in 2018 and 2.4% in 2021, with the frequency decreasing each year. The incidence of postoperative complications ranged from 14.6% to 16.6%, and the 90-day mortality rate ranged from 0.3% to 0.5%, with no remarkable change within the study period.</p><p><strong>Conclusions: </strong>The initial perioperative outcomes of RATS for lung cancer in Japan were favorable. Further accumulation of cases and comparative analyses of long-term outcomes with other approaches are expected.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"1124-1131"},"PeriodicalIF":1.6000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery Today","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00595-025-02992-5","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/7 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To analyze the clinicopathological features and perioperative outcomes of patients who underwent robot-assisted thoracoscopic surgery (RATS) for primary lung cancer in the initial period after insurance approval in Japan.

Methods: The data source was the National Clinical Database, using four annual datasets (2018, 2019, 2020, and 2021) that included information on individuals who underwent lobectomy with lymph-node dissection via robot-assisted thoracoscopic surgery for primary lung cancer. Clinicopathological features and perioperative outcomes by year were analyzed descriptively.

Results: The median console time was reduced by 22 min from 2018 to 2021 (from 171 min to 149 min, respectively). The median overall operative time was also reduced by 29 min from 2018 to 2021 (from 245 min to 216 min, respectively). The conversion rate from robotic to other approaches was 3.5% in 2018 and 2.4% in 2021, with the frequency decreasing each year. The incidence of postoperative complications ranged from 14.6% to 16.6%, and the 90-day mortality rate ranged from 0.3% to 0.5%, with no remarkable change within the study period.

Conclusions: The initial perioperative outcomes of RATS for lung cancer in Japan were favorable. Further accumulation of cases and comparative analyses of long-term outcomes with other approaches are expected.

机器人辅助胸腔镜手术治疗原发性肺癌的临床病理特征和围手术期结果:基于国家临床数据库的初步结果分析
目的:分析日本机器人辅助胸腔镜手术(RATS)治疗原发性肺癌患者在保险批准后初期的临床病理特征和围手术期结局。方法:数据来源是国家临床数据库,使用四个年度数据集(2018年、2019年、2020年和2021年),其中包括通过机器人辅助胸腔镜手术进行肺叶切除术并淋巴结清扫的原发性肺癌患者的信息。回顾性分析两组患者的临床病理特征及围手术期预后。结果:从2018年到2021年,中位控制台时间减少了22分钟(分别从171分钟减少到149分钟)。从2018年到2021年,中位总手术时间也减少了29分钟(分别从245分钟减少到216分钟)。从机器人到其他方法的转化率在2018年为3.5%,在2021年为2.4%,频率每年都在下降。术后并发症发生率为14.6% ~ 16.6%,90天死亡率为0.3% ~ 0.5%,研究期间无明显变化。结论:在日本,rat治疗肺癌的初步围手术期结果是良好的。期望进一步积累案例并与其他方法进行长期结果的比较分析。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Surgery Today
Surgery Today 医学-外科
CiteScore
4.90
自引率
4.00%
发文量
208
审稿时长
1 months
期刊介绍: Surgery Today is the official journal of the Japan Surgical Society. The main purpose of the journal is to provide a place for the publication of high-quality papers documenting recent advances and new developments in all fields of surgery, both clinical and experimental. The journal welcomes original papers, review articles, and short communications, as well as short technical reports("How to do it"). The "How to do it" section will includes short articles on methods or techniques recommended for practical surgery. Papers submitted to the journal are reviewed by an international editorial board. Field of interest: All fields of surgery.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信